Is TDSGF or DIVO a better dividend investment in 2026?

TDSGF currently yields 5555.56% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: TDSGF offers higher current income.

What is the dividend yield difference between TDSGF and DIVO?

TDSGF has a forward dividend yield of 5555.56% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 5549.07 percentage points.

Home › Compare › TDSGF vs DIVO

TDSGF vs DIVO: Dividend Comparison 2026

TDSGF yields 5555.56% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TDSGF wins by $173383299298071.97M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TDSGF

● Live price

5555.56%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$173383299298072.00M

Annual income

$167,453,967,894,000,300,000.00

Full TDSGF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — TDSGF vs DIVO

📍 TDSGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TDSGF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TDSGF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TDSGF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TDSGF

Annual income on $10K today (after 15% tax)

$472,222.22/yr

After 10yr DRIP, annual income (after tax)

$142,335,872,709,900,260,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, TDSGF beats the other by $142,335,872,709,900,260,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TDSGF + DIVO for your $10,000?

TDSGF: 50%DIVO: 50%

100% DIVO50/50100% TDSGF

Portfolio after 10yr

$86691649649036.02M

Annual income

$83,726,983,947,000,150,000.00/yr

Blended yield

96.58%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TDSGF buys

DIVO buys

No recent congressional trades found for TDSGF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTDSGFDIVO

Forward yield	5555.56% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$173383299298072.00M ✓	$30.7K
Annual income after 10y	$167,453,967,894,000,300,000.00 ✓	$981.68
Total dividends collected	$172983452329089.31M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TDSGF vs DIVO ($10,000, DRIP)

Year	TDSGF Portfolio	TDSGF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$566,256	$555,555.56	$11,349	$649.42	+$554.9K → TDSGF
2	$30,006,493	$29,400,599.98	$12,833	$688.83	+$29.99M → TDSGF
3	$1,488,153,251	$1,456,046,302.99	$14,459	$727.90	+$1488.14M → TDSGF
4	$69,079,898,381	$67,487,574,402.39	$16,238	$766.49	+$69079.88M → TDSGF
5	$3,001,733,475,908	$2,927,817,984,640.30	$18,179	$804.47	+$3001733.46M → TDSGF
6	$122,111,548,308,987	$118,899,693,489,765.72	$20,293	$841.71	+$122111548.29M → TDSGF
7	$4,651,108,281,906,614	$4,520,448,925,215,998.00	$22,591	$878.14	+$4651108281.88M → TDSGF
8	$165,892,045,974,674,900	$160,915,360,113,034,850.00	$25,087	$913.65	+$165892045974.65M → TDSGF
9	$5,541,431,218,758,608,000	$5,363,926,729,565,706,000.00	$27,791	$948.18	+$5541431218758.58M → TDSGF
10	$173,383,299,298,072,000,000	$167,453,967,894,000,300,000.00	$30,718	$981.68	+$173383299298071.97M → TDSGF

TDSGF vs DIVO: Complete Analysis 2026

TDSGF — Stock

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.

Full TDSGF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this TDSGF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TDSGF vs SCHD TDSGF vs JEPI TDSGF vs O TDSGF vs KO TDSGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.